about
Understanding pRb: toward the necessary development of targeted treatments for retinoblastomaSolid tumor second primary neoplasms: who is at risk, what can we do?Aminoimidazole carboxamide ribonucleotide (AICAR) inhibits the growth of retinoblastoma in vivo by decreasing angiogenesis and inducing apoptosisWhole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: a pilot study.Twenty-Year Collaboration Between North American and South American Retinoblastoma Programs.Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in malesRisk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapyRetinoblastoma treatment burden and economic cost: impact of age at diagnosis and selection of primary therapy.Cognitive function and social attainment in adult survivors of retinoblastoma: a report from the St. Jude Lifetime Cohort Study.Increased cortical surface area and gyrification following long-term survival from early monocular enucleation.Colorimetric and longitudinal analysis of leukocoria in recreational photographs of children with retinoblastoma.Challenging issues in pediatric oncologyAt-risk populations for osteosarcoma: the syndromes and beyond.Sporadic Retinoblastoma and Parental Smoking and Alcohol Consumption before and after Conception: A Report from the Children's Oncology Group.Pars Plana Vitrectomy and Evisceration Resulting in Death Due to Misdiagnosis of Retinoblastoma in Children: A Review of 3 Cases.Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma.MRI helps depict clinically undetectable risk factors in advanced stage retinoblastomas.Incidence and survival of retinoblastoma in Taiwan: a nationwide population-based study 1998-2011"Retinoblastoma survival disparity": The expanding horizon in developing countries.Altered anterior visual system development following early monocular enucleation.Inhibitory effect of bufalin on retinoblastoma cells (HXO-RB44) via the independent mitochondrial and death receptor pathway.Impact of socioeconomic disparities on cause-specific survival of retinoblastomaSuperselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution.Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma.Therapeutic Options for Retinoblastoma.A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt.Matrine inhibits the growth of retinoblastoma cells (SO-Rb50) by decreasing proliferation and inducing apoptosis in a mitochondrial pathway.Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group.Tandem therapy for retinoblastoma: immunotherapy and chemotherapy enhance cytotoxicity on retinoblastoma by increasing apoptosis.Obesity-associated digestive cancers: A review of mechanisms and interventions.A retrospective analysis of severe intraoperative respiratory compliance changes during ophthalmic arterial chemosurgery for retinoblastoma.Blockade of sonic hedgehog signaling decreases viability and induces apoptosis in retinoblastoma cells: The key role of the PI3K/Akt pathway.Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells.Childhood cancer and developmental biology a crucial partnership.Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments.A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends.Epidemiological trends in 1452 cases of retinoblastoma from the Surveillance, Epidemiology, and End Results (SEER) registry.Improved procedural safety following protocol changes for selective ophthalmic arterial infusion of chemotherapy for treatment of ocular retinoblastoma.
P2860
Q27011911-EAE09350-A208-48AF-95D9-19E7695929ACQ27026266-E3013B66-4DAB-4060-82E8-25F024318F31Q28484822-2890F775-CDDE-44C6-9A70-A27277C8010CQ33555866-37F558CC-F8F7-4C3F-973A-4766EE106FD2Q33859636-BCBE291A-4894-4822-A30E-026B0F9B44B6Q34017134-9EDD8209-3F03-444A-A498-205CA160BD65Q34117529-27667D96-6954-4746-841B-8C265EDA9218Q34260518-5DC0C612-E7A4-4876-B13D-AAC79015D2E8Q34440524-8D958744-1866-48B5-BD51-489AA5A79999Q34734620-66E45725-CB27-41E4-97A1-1CD257339950Q34988685-8D4D8652-3698-4176-A9C1-ADD8B078F8F4Q35034754-BB845225-D999-4694-9E41-06E1CA1504A7Q35602419-79123115-2EB6-4800-8B59-4D1919C82D28Q35897747-B020A2B5-A6D3-4CD9-A828-6C735A98A8BCQ35962597-1B64CBF2-F3B7-47DC-8D74-6E83092810C6Q36195187-037EB6BA-311D-4900-AD97-3746DD9D324CQ36225245-080CBC03-F087-4B56-B554-9A42FAE0CF81Q36589627-3E81AAB3-0A56-4C04-80E4-0EEE6AFC5034Q36968693-64582AED-286B-44F5-AE35-0E6091BED2B7Q37060541-0F1DD72E-47C6-4883-A5D3-CB8F2109B976Q37368870-74E3B9B6-E771-4D9D-BDC6-95BCD00F8EECQ37448208-437525DA-91F2-4708-AA86-AEA6D10F7A74Q37560905-EE0EB45B-DCE1-4559-AD5C-3563466BDE02Q38118753-DEC830A8-B036-4092-B719-30256483AF0CQ38653083-CBFA906E-EAF5-4CEC-A7A7-D44CDB633EBEQ38737526-175D7503-DABD-461D-8906-90C16A5E369FQ38842907-F4B4A61E-8B02-4B2F-8DFD-224E65225C5AQ38868310-C928DCB2-2EF4-4A1B-8E39-F4D0E3B9D484Q39025180-A6968C94-528C-4496-8430-C6669586FC79Q39055366-E2221E45-B63C-4E72-A1CE-E00BCC9ADBC1Q39149552-0F1D42DD-249D-4BD5-B1F1-05C1BDDEAF51Q39205170-A53722B9-9713-4CFD-8788-387F55A9FCCAQ41615149-B1628C08-0E9E-4D1E-A913-88232D7A8DE6Q41701864-EF137923-C88F-48A0-AF65-D6F32B3B8688Q41761751-D6EBE233-28CD-4408-A3ED-77422F8DF435Q42917104-6A1E05CE-D872-466A-A68F-08F24D384FDFQ44974340-248F7A82-FB06-4B96-B4BE-2C968D318D73Q45983103-438BDC15-1D4B-4BFA-B0F5-30327A56D1DDQ50025544-A31DF358-AF40-4B34-B8C9-84B1CC078913Q50046630-251854AC-E98E-4F7D-BC10-F344D6F805B3
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Survival with retinoblastoma in the USA: 1975-2004.
@en
Survival with retinoblastoma in the USA: 1975-2004.
@nl
type
label
Survival with retinoblastoma in the USA: 1975-2004.
@en
Survival with retinoblastoma in the USA: 1975-2004.
@nl
prefLabel
Survival with retinoblastoma in the USA: 1975-2004.
@en
Survival with retinoblastoma in the USA: 1975-2004.
@nl
P2093
P356
P1476
Survival with retinoblastoma in the USA: 1975-2004.
@en
P2093
P356
10.1136/BJO.2008.143842
P407
P577
2008-08-21T00:00:00Z